rs201815496

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The NM_017950.4(CCDC40):​c.697G>A​(p.Asp233Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000268 in 1,613,598 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. D233D) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00018 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00028 ( 0 hom. )

Consequence

CCDC40
NM_017950.4 missense

Scores

19

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:1

Conservation

PhyloP100: -0.310

Publications

2 publications found
Variant links:
Genes affected
CCDC40 (HGNC:26090): (coiled-coil domain 40 molecular ruler complex subunit) This gene encodes a protein that is necessary for motile cilia function. It functions in correct left-right axis formation by regulating the assembly of the inner dynein arm and the dynein regulatory complexes, which control ciliary beat. Mutations in this gene cause ciliary dyskinesia type 15, a disorder due to defects in cilia motility. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2011]
CCDC40 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 15
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia, Laboratory for Molecular Medicine
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autoimmune disease
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.045936316).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CCDC40NM_017950.4 linkc.697G>A p.Asp233Asn missense_variant Exon 5 of 20 ENST00000397545.9 NP_060420.2
CCDC40NM_001243342.2 linkc.697G>A p.Asp233Asn missense_variant Exon 5 of 18 NP_001230271.1
CCDC40NM_001330508.2 linkc.697G>A p.Asp233Asn missense_variant Exon 5 of 11 NP_001317437.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CCDC40ENST00000397545.9 linkc.697G>A p.Asp233Asn missense_variant Exon 5 of 20 5 NM_017950.4 ENSP00000380679.4

Frequencies

GnomAD3 genomes
AF:
0.000184
AC:
28
AN:
152126
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000193
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000191
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000218
AC:
54
AN:
247472
AF XY:
0.000230
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000580
Gnomad ASJ exome
AF:
0.000199
Gnomad EAS exome
AF:
0.000390
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000251
Gnomad OTH exome
AF:
0.000497
GnomAD4 exome
AF:
0.000278
AC:
406
AN:
1461354
Hom.:
0
Cov.:
33
AF XY:
0.000286
AC XY:
208
AN XY:
726972
show subpopulations
African (AFR)
AF:
0.0000896
AC:
3
AN:
33470
American (AMR)
AF:
0.000134
AC:
6
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.000268
AC:
7
AN:
26134
East Asian (EAS)
AF:
0.000101
AC:
4
AN:
39696
South Asian (SAS)
AF:
0.000429
AC:
37
AN:
86246
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53258
Middle Eastern (MID)
AF:
0.00262
AC:
15
AN:
5730
European-Non Finnish (NFE)
AF:
0.000286
AC:
318
AN:
1111732
Other (OTH)
AF:
0.000265
AC:
16
AN:
60368
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
26
51
77
102
128
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000177
AC:
27
AN:
152244
Hom.:
0
Cov.:
32
AF XY:
0.000161
AC XY:
12
AN XY:
74442
show subpopulations
African (AFR)
AF:
0.000193
AC:
8
AN:
41536
American (AMR)
AF:
0.00
AC:
0
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.000576
AC:
2
AN:
3470
East Asian (EAS)
AF:
0.000387
AC:
2
AN:
5172
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000191
AC:
13
AN:
68000
Other (OTH)
AF:
0.000473
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000281
Hom.:
0
Bravo
AF:
0.000155
ExAC
AF:
0.000215
AC:
26
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.000327
EpiControl
AF:
0.000533

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 23, 2023
Mayo Clinic Laboratories, Mayo Clinic
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

BP4 -

Primary ciliary dyskinesia Uncertain:1Benign:1
Dec 03, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 233 of the CCDC40 protein (p.Asp233Asn). This variant is present in population databases (rs201815496, gnomAD 0.04%). This missense change has been observed in individual(s) with clinical features of CCDC40-related conditions (PMID: 34768622). ClinVar contains an entry for this variant (Variation ID: 583321). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Dec 05, 2023
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Primary ciliary dyskinesia 15 Uncertain:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.078
BayesDel_addAF
Benign
-0.51
T
BayesDel_noAF
Benign
-0.65
CADD
Benign
3.1
DANN
Benign
0.93
DEOGEN2
Benign
0.061
.;T;.;.
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.031
N
LIST_S2
Benign
0.49
T;T;T;T
M_CAP
Benign
0.0095
T
MetaRNN
Benign
0.046
T;T;T;T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
0.55
N;N;N;N
PhyloP100
-0.31
PrimateAI
Benign
0.31
T
PROVEAN
Benign
-0.40
N;N;N;N
REVEL
Benign
0.020
Sift
Benign
0.078
T;T;D;D
Sift4G
Benign
0.29
T;T;T;T
Polyphen
0.80, 0.20
.;P;.;B
Vest4
0.12
MVP
0.17
MPC
0.21
ClinPred
0.0076
T
GERP RS
-4.5
Varity_R
0.035
gMVP
0.042
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201815496; hg19: chr17-78022402; COSMIC: COSV53898699; COSMIC: COSV53898699; API